Cargando…
Anti-proliferative activity of epigallocatechin-3-gallate and silibinin on soft tissue sarcoma cells
Disseminated soft tissue sarcomas (STS) present a therapeutic dilemma. The first-line cytostatic doxorubicin demonstrates a response rate of 30% and is not suitable for elderly patients with underlying cardiac disease, due to its cardiotoxicity. Well-tolerated alternative treatment options, particul...
Autores principales: | Harati, Kamran, Behr, Björn, Wallner, Christoph, Daigeler, Adrien, Hirsch, Tobias, Jacobsen, Frank, Renner, Marcus, Harati, Ali, Lehnhardt, Marcus, Becerikli, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355719/ https://www.ncbi.nlm.nih.gov/pubmed/27909727 http://dx.doi.org/10.3892/mmr.2016.5969 |
Ejemplares similares
-
Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells
por: HARATI, KAMRAN, et al.
Publicado: (2016) -
Reconstructive Options for Oncologic Posterior Trunk Defects: A Review
por: Behr, Björn, et al.
Publicado: (2016) -
Reconstruction of Soft-Tissue Defects at the Foot and Ankle after Oncological Resection
por: Ring, Andrej, et al.
Publicado: (2016) -
Effect of surgical margins on prognosis in aggressive fibromatosis: A single-institutional analysis of 90 patients
por: Harati, Kamran, et al.
Publicado: (2017) -
Negative Impact of Wound Complications on Oncologic Outcome of Soft Tissue Sarcomas of the Chest Wall
por: Dadras, Mehran, et al.
Publicado: (2019)